SGHT Stock Analysis: Buy, Sell, or Hold?
SGHT - Sight Sciences, Inc. Common Stock
$3.66
-0.22 (-5.67%)
▼
5d:
+0.83%
30d:
-29.07%
90d:
-58.5%
BUY
HIGH Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 14, 2026
Smart Money Accumulation
SGHT is down 23.8% this week, but smart money is accumulating calls. Top strike: $5 2026-05-15 with 421 OI. Call ratio: 100% View Scanner →
Strength: 10.0/10
Get Alerted When SGHT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: SGHT shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: SGHT shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: SGHT is currently trading at $3.66, which is considered slightly low relative to its 30-day fair value range of $3.58 to $5.11.
Technical Outlook: Technically, SGHT is in a strong downtrend. Immediate support is located at $3.41, while resistance sits at $4.11. Short-term momentum is weak, with the stock down 5.7% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $8.50 (+119.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SGHT is in a strong downtrend. Immediate support is located at $3.41, while resistance sits at $4.11. Short-term momentum is weak, with the stock down 5.7% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $8.50 (+119.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$3.58 -
$5.11
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.7%)
- BULLISH: Trading 119.1% below Wall St target ($8.50)
Fair Price Analysis
30-Day Fair Range
$3.58 -
$5.11
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$3.41
Resistance Level
$4.11
Current Trend
Strong Downtrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.97
Wall Street Target
$8.50
(+119.1%)
Revenue Growth (YoY)
6.9%
Profit Margin
-49.7%
Share & Embed Analysis
Last updated: March 30, 2026 2:52 PM ET
Data refreshes hourly during market hours. Next update: 3:52 PM
Data refreshes hourly during market hours. Next update: 3:52 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SGHT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
James Rodberg
SELL
2616 shares
2026-01-16
Jeremy B Hayden
SELL
6308 shares
2026-01-16
Paul Badawi
SELL
22362 shares
2026-01-16
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$102 | 60 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 56 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$86 | 51 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$133 | 61 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 63 BUY |
